Stay updated on IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check23 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check52 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial involving MOR106 for atopic dermatitis, while retaining the mention of the drug and its EudraCT number.SummaryDifference25%
- Check73 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.